Can Fluconazole Cause Acute Kidney Injury?
Fluconazole is not a direct nephrotoxin and does not commonly cause acute kidney injury (AKI) as a primary adverse effect. However, it can contribute to AKI through indirect mechanisms, particularly when combined with other nephrotoxic agents or in patients with pre-existing renal dysfunction.
Direct Nephrotoxicity Evidence
The evidence consistently demonstrates that fluconazole has minimal direct nephrotoxic potential:
- A large population-based study of 54,803 patients found no cases of serious adverse kidney events attributable to fluconazole, with a rate of 0/100,000 prescriptions for renal toxicity 1
- Among antifungal agents, amphotericin B deoxycholate has the highest nephrotoxicity potential, followed by lipid formulations of amphotericin B, while triazoles (including fluconazole) have "much lesser extent" nephrotoxicity only through indirect mechanisms 2
Indirect Mechanisms and Drug Interactions
The primary concern with fluconazole and kidney injury relates to drug-drug interactions rather than direct toxicity:
- Fluconazole significantly increases the risk of vancomycin-induced nephrotoxicity (OR 3.326, p=0.018), making it a potential risk factor when these drugs are combined 3
- As a moderate CYP3A4 and CYP2C9 inhibitor and strong CYP2C19 inhibitor, fluconazole can increase levels of other nephrotoxic medications 4
Dosing Considerations in Renal Dysfunction
Fluconazole requires dose adjustment in patients with existing renal impairment, not because it causes AKI, but because it is primarily renally cleared:
- Approximately 80% of fluconazole is excreted unchanged in urine 4
- The elimination half-life has an inverse relationship with creatinine clearance 4
- Guidelines consistently recommend dose adjustment based on renal function, particularly noting that high-dose fluconazole (400-1200 mg daily) should only be used in patients with "normal renal function" 5
Clinical Monitoring Recommendations
When using fluconazole:
- Monitor renal function in elderly patients who are more likely to have decreased baseline renal function 4
- Exercise caution when combining with known nephrotoxins, particularly vancomycin, loop diuretics (furosemide, torasemide), and other azoles like voriconazole 3
- Adjust doses appropriately in patients with creatinine clearance <50 mL/min, though this is for drug accumulation prevention rather than nephrotoxicity prevention 4
Special Populations
In critically ill patients on continuous renal replacement therapy (CVVHD), higher doses of fluconazole (at least 400 mg twice daily) are needed to achieve therapeutic targets, demonstrating that the drug is efficiently removed by dialysis rather than accumulating to cause toxicity 6.
Bottom line: Fluconazole does not directly cause AKI but requires dose adjustment in renal impairment due to renal clearance, and can potentiate nephrotoxicity of other agents through drug interactions.